Spots Global Cancer Trial Database for An Open-label, Single Dose Pharmacokinetic Study of 14 mg Granisetron Patch in Healthy Subjects

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Open-label, Single Dose Pharmacokinetic Study of 14 mg Granisetron Patch in Healthy Subjects

Official Title: An Open-label, Single Dose Pharmacokinetic Study of 14 mg Granisetron Patch in Healthy Subjects

Study ID: NCT00954291

Conditions

Cancer

Vomiting

Interventions

Study Description

Brief Summary: The objective of the study is to characterize the pharmacokinetic profile of granisetron patch after single administration to healthy subjects.

Detailed Description: The objective of the study is to characterize the pharmacokinetic profile of granisetron patch after single administration to healthy subjects.